Literature DB >> 12241545

Substrate specificity of the metalloproteinase pregnancy-associated plasma protein-A (PAPP-A) assessed by mutagenesis and analysis of synthetic peptides: substrate residues distant from the scissile bond are critical for proteolysis.

Lisbeth S Laursen1, Michael T Overgaard, Claus G Nielsen, Henning B Boldt, Kathrin H Hopmann, Cheryl A Conover, Lars Sottrup-Jensen, Linda C Giudice, Claus Oxvig.   

Abstract

Human pregnancy-associated plasma protein-A (PAPP-A) cleaves insulin-like growth factor (IGF) binding protein-4 (IGFBP-4), causing a dramatic reduction in its affinity for IGF-I and -II. Through this mechanism, PAPP-A is a regulator of IGF bioactivity in several systems, including the human ovary and the cardiovascular system. PAPP-A belongs to the metzincin superfamily of zinc metalloproteinases, and is the founding member of a fifth metzincin family, the pappalysins. Herein, we first determined that PAPP-A cleaves IGFBP-4 at a single site (Met-135/Lys-136), and we analysed the influence of ionic strength, pH and zinc ion concentration on the cleavage reaction. Secondly, we sought to delineate the role of substrate residues in PAPP-A-mediated cleavage by the construction and analysis of 30 IGFBP-4 mutants in which various residues were replaced by alanine, by the analysis of eight mutants of IGFBP-5 (found recently to be a second PAPP-A substrate), and by cleavage analysis of synthetic peptides derived from IGFBP-4. Our data reveal a complex mode of substrate recognition and/or binding, pointing at important roles for several basic residues located up to 16 residues N-terminal to the scissile bond. An unexpected parallel can be drawn with an intracellular enzyme, the mitochondrial processing peptidase, that may help us to understand properties of the pappalysins. Further, proteinase-resistant variants of IGFBP-4 and -5, presented here, will be useful tools for the study of proteolysis in cell-based systems, and our finding that a synthetic peptide can be cleaved by PAPP-A provides the basis for development of quantitative assays for the investigation of PAPP-A enzyme kinetics.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12241545      PMCID: PMC1222882          DOI: 10.1042/BJ20020831

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  49 in total

Review 1.  Mitochondrial processing peptidase: multiple-site recognition of precursor proteins.

Authors:  A Ito
Journal:  Biochem Biophys Res Commun       Date:  1999-11-30       Impact factor: 3.575

2.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

Authors:  F C GREENWOOD; W M HUNTER; J S GLOVER
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

3.  Studies on human pregnancy-induced insulin-like growth factor (IGF)-binding protein-4 proteases in serum: determination of IGF-II dependency and localization of cleavage site.

Authors:  D Byun; S Mohan; C Kim; K Suh; M Yoo; H Lee; D J Baylink; X Qin
Journal:  J Clin Endocrinol Metab       Date:  2000-01       Impact factor: 5.958

4.  Studies on the role of human insulin-like growth factor-II (IGF-II)-dependent IGF binding protein (hIGFBP)-4 protease in human osteoblasts using protease-resistant IGFBP-4 analogs.

Authors:  X Qin; D Byun; D D Strong; D J Baylink; S Mohan
Journal:  J Bone Miner Res       Date:  1999-12       Impact factor: 6.741

5.  Evidence that the interaction between insulin-like growth factor (IGF)-II and IGF binding protein (IGFBP)-4 is essential for the action of the IGF-II-dependent IGFBP-4 protease.

Authors:  X Qin; D Byun; K H Lau; D J Baylink; S Mohan
Journal:  Arch Biochem Biophys       Date:  2000-07-15       Impact factor: 4.013

6.  Partial IGF affinity of circulating N- and C-terminal fragments of human insulin-like growth factor binding protein-4 (IGFBP-4) and the disulfide bonding pattern of the C-terminal IGFBP-4 domain.

Authors:  L Ständker; T Braulke; S Mark; H Mostafavi; M Meyer; S Höning; G Giménez-Gallego; W G Forssmann
Journal:  Biochemistry       Date:  2000-05-02       Impact factor: 3.162

7.  Expression of recombinant human pregnancy-associated plasma protein-A and identification of the proform of eosinophil major basic protein as its physiological inhibitor.

Authors:  M T Overgaard; J Haaning; H B Boldt; I M Olsen; L S Laursen; M Christiansen; G J Gleich; L Sottrup-Jensen; C A Conover; C Oxvig
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

8.  The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A.

Authors:  J B Lawrence; C Oxvig; M T Overgaard; L Sottrup-Jensen; G J Gleich; L G Hays; J R Yates; C A Conover
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

9.  Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3.

Authors:  G A McQuibban; J H Gong; E M Tam; C A McCulloch; I Clark-Lewis; C M Overall
Journal:  Science       Date:  2000-08-18       Impact factor: 47.728

10.  Insulin-like growth factor binding protein-4 proteolytic degradation in ovine preovulatory follicles: studies of underlying mechanisms.

Authors:  S Mazerbourg; J Zapf; R S Bar; D R Brigstock; C Lalou; M Binoux; P Monget
Journal:  Endocrinology       Date:  1999-09       Impact factor: 4.736

View more
  21 in total

1.  Pregnancy-associated plasma protein A (PAPP-A) modulates the early developmental rate in zebrafish independently of its proteolytic activity.

Authors:  Kasper Kjaer-Sorensen; Ditte H Engholm; Hiroyasu Kamei; Maria G Morch; Anisette O Kristensen; Jianfeng Zhou; Cheryl A Conover; Cunming Duan; Claus Oxvig
Journal:  J Biol Chem       Date:  2013-02-19       Impact factor: 5.157

2.  Stanniocalcin-2 inhibits mammalian growth by proteolytic inhibition of the insulin-like growth factor axis.

Authors:  Malene R Jepsen; Søren Kløverpris; Jakob H Mikkelsen; Josefine H Pedersen; Ernst-Martin Füchtbauer; Lisbeth S Laursen; Claus Oxvig
Journal:  J Biol Chem       Date:  2014-12-22       Impact factor: 5.157

Review 3.  Key questions and answers about pregnancy-associated plasma protein-A.

Authors:  Cheryl A Conover
Journal:  Trends Endocrinol Metab       Date:  2012-03-28       Impact factor: 12.015

4.  In vivo analysis of gene expression in long-lived mice lacking the pregnancy-associated plasma protein A (PappA) gene.

Authors:  William R Swindell; Michal M Masternak; Andrzej Bartke
Journal:  Exp Gerontol       Date:  2010-03-01       Impact factor: 4.032

5.  The role of PAPP-A in the IGF system: location, location, location.

Authors:  Claus Oxvig
Journal:  J Cell Commun Signal       Date:  2015-01-25       Impact factor: 5.782

6.  Lack of functional pregnancy-associated plasma protein-A (PAPPA) compromises mouse ovarian steroidogenesis and female fertility.

Authors:  Mette Nyegaard; Michael T Overgaard; You-Qiang Su; Amy E Hamilton; Jakub Kwintkiewicz; Minnie Hsieh; Nihar R Nayak; Marco Conti; Cheryl A Conover; Linda C Giudice
Journal:  Biol Reprod       Date:  2010-02-03       Impact factor: 4.285

Review 7.  Gestational Diabetes Mellitus and Energy-Dense Diet: What Is the Role of the Insulin/IGF Axis?

Authors:  Irene Martín-Estal; Fabiola Castorena-Torres
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-23       Impact factor: 6.055

8.  Structure of the proteolytic enzyme PAPP-A with the endogenous inhibitor stanniocalcin-2 reveals its inhibitory mechanism.

Authors:  Sara Dam Kobberø; Michael Gajhede; Osman Asghar Mirza; Søren Kløverpris; Troels Rønn Kjær; Jakob Hauge Mikkelsen; Thomas Boesen; Claus Oxvig
Journal:  Nat Commun       Date:  2022-10-18       Impact factor: 17.694

Review 9.  Biomarkers in acute myocardial infarction.

Authors:  Daniel Chan; Leong L Ng
Journal:  BMC Med       Date:  2010-06-07       Impact factor: 8.775

10.  Integrated analysis of gene expression profiles associated with response of platinum/paclitaxel-based treatment in epithelial ovarian cancer.

Authors:  Yong Han; Hao Huang; Zhen Xiao; Wei Zhang; Yanfei Cao; Like Qu; Chengchao Shou
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.